Epidemiology of nosocomial fungal infections: Evolution and trends;Epidemiologie des infections nosocomiales fongiques: Evolution et tendances

Medecine Therapeutique

Volumn 6, Issue SUPPL. 1, 2000, Pages 24-31

  Bougnoux, M E ^a   Kac, G ^a   Espinasse, F ^a  

^a HÔPITAL AMBROISE PARÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; KETOCONAZOLE;

ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA TROPICALIS; CHEMOPROPHYLAXIS; DISEASE TRANSMISSION; HOSPITAL INFECTION; INCIDENCE; INFECTION RISK; MYCOSIS; REVIEW;

EID: 0033889675     PISSN: 12646520     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Secular trends in the epidemiology of nosocomial fungal infections in the United States 1980-1990
2. Enquete nationale de prevalence des infections nosocomiales
3. Epidemiology of Candida infection
4. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance
5. Trends in species distribution and susceptibility to fluconazole among bloodstream isolates of Candida species in the United States
6. Major trends in microbial etiology of nosocomial infection
7. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989
8. National nososcomial infections surveillance system 1999. Nosocomial infections in medical intensive care units in the United states
9. Prevalence and risk factors for nosocomial infections in four university hospitals in Switzerland
10. Incidence of candidemia in French hospitals, 1995
11. Gastrointestinal colonization and systemic dissemination by Candida albicans and Candida tropicalis in intact and immunocomprised mice
12. Candidemia in cancer patients: A prospective, multicenter surveillance study by the invasive fungal group (IFIG) of the european organization for research and treatment of cancer (EORTC)
13. Genotypic variation and slime production among blood and catheter isolates of Candida parapsilosis
14. Nosocomial Candida glabrata colonization: An epidemiologic study
15. Nosocomial acquisition of Candida albicans: An epidemiologic study
16. Characterization of the sequence of colonization and nosocomial candidemia using DNA fingerprinting and a DNA probe
17. Use of random amplified polymorphic DNA as a typing method for Candida albicans in epidemiological surveillance of a burn unit
18. Investigation of the sequence of colonization and candidemia in nonneutropenic patients
19. Risk factors for candidemia in cancer patients: A case-control study
20. Risk factors for hospital-acquired candidemia
21. An experimental model for study of Candida survival and transmission in human volonteers
22. High frequency of yeast carriage on hands of hospital personnel
23. Yeast carriage on hands of hospital personnel working in intensive care units
24. Restriction fragment analysis of a Candida tropicalis of sternal wound infections
25. Fluconazole susceptibilities of Candida sp. and distribution of species recovered from blood cultures over a 5-year period
26. The epidemiology of hematogenous candidiasis caused by different Candida species
27. Trends in antifungal use and epidemiology of nosocomial yeast infections in a university hospital
28. Hospital-acquired candidemia: The attributable mortality and excess length of stay
29. The impact of candidemia on length of hospital stay, outcome, and overall cost of illness
30. Microbiological factors influencing the outcome of nosocomial bloodstream infections: A 6-year validated, population-based model
31. Aspergillose invasive: Origine nosocomiale des epidemies. Mise au point
32. Prevention of nosocomial aspergillosis
33. Invasive aspergillosis
34. Epidemiology of visceral mycoses: Analysis of data in annual of the pathological autopsy cases in Japan
35. Aspergilloses
36. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone transplantation
37. Genetic diversity among clinical and environmental isolates of Aspergillus fumigatus
38. Molecular typing of environmental and patients isolates of Aspergillus fumigatus from various hospital settings
39. Use of randomly amplified polymorphic DNA markers (RAPD) demonstrated the nosocomial contamination in a case of lethal invasive aspergillosis
40. Density and molecular epidemiology of Aspergillus in air and relationship to outbreaks of Aspergillus infections
41. Impact of air filtration on nosocomial Aspergillus infections
42. In vitro susceptibilities of Candida bloodstream isolates to the new triazole antifungal agents BMS-207147, Sch 56592, and voriconazole
43. Importance of Candida species other than C. albicansas pathogens in oncology patients
44. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia